Franc Anderluh

484 total citations
31 papers, 369 citations indexed

About

Franc Anderluh is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Franc Anderluh has authored 31 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 19 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Franc Anderluh's work include Colorectal and Anal Carcinomas (19 papers), Colorectal Cancer Surgical Treatments (17 papers) and Gastric Cancer Management and Outcomes (11 papers). Franc Anderluh is often cited by papers focused on Colorectal and Anal Carcinomas (19 papers), Colorectal Cancer Surgical Treatments (17 papers) and Gastric Cancer Management and Outcomes (11 papers). Franc Anderluh collaborates with scholars based in Slovenia, Netherlands and Germany. Franc Anderluh's co-authors include Vaneja Velenik, Irena Oblak, Janja Ocvirk, Mirko Omejc, Erik Brecelj, Ibrahim Edhemović, Primož Strojan, Branko Zakotnik, Maja Marolt Mušič and Matej Bračko and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Franc Anderluh

28 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franc Anderluh Slovenia 11 256 251 99 27 24 31 369
Lucyna Pietrzak Poland 11 278 1.1× 249 1.0× 82 0.8× 39 1.4× 44 1.8× 20 394
Mara Gisabella Italy 7 182 0.7× 103 0.4× 199 2.0× 39 1.4× 19 0.8× 10 345
Giovanni Boz Italy 9 218 0.9× 134 0.5× 89 0.9× 18 0.7× 17 0.7× 19 303
R. Innocente Italy 11 336 1.3× 300 1.2× 171 1.7× 32 1.2× 19 0.8× 42 481
Christian Sturesson Sweden 12 255 1.0× 213 0.8× 98 1.0× 33 1.2× 5 0.2× 38 377
Alice Dewdney United Kingdom 8 398 1.6× 304 1.2× 100 1.0× 27 1.0× 10 0.4× 18 440
P Ségol France 4 275 1.1× 150 0.6× 110 1.1× 36 1.3× 9 0.4× 11 391
T Kobayashi Japan 6 194 0.8× 125 0.5× 219 2.2× 11 0.4× 15 0.6× 14 340
Shinsuke Masubuchi Japan 12 214 0.8× 248 1.0× 116 1.2× 17 0.6× 6 0.3× 39 412
Nadim Bashir United Kingdom 5 106 0.4× 232 0.9× 233 2.4× 23 0.9× 9 0.4× 5 316

Countries citing papers authored by Franc Anderluh

Since Specialization
Citations

This map shows the geographic impact of Franc Anderluh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franc Anderluh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franc Anderluh more than expected).

Fields of papers citing papers by Franc Anderluh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franc Anderluh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franc Anderluh. The network helps show where Franc Anderluh may publish in the future.

Co-authorship network of co-authors of Franc Anderluh

This figure shows the co-authorship network connecting the top 25 collaborators of Franc Anderluh. A scholar is included among the top collaborators of Franc Anderluh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franc Anderluh. Franc Anderluh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterlin, Primož, et al.. (2024). Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT. Radiology and Oncology. 58(4). 580–587.
2.
Anderluh, Franc, et al.. (2019). Definitive radiochemotherapy in esophageal cancer - a single institution experience. Radiology and Oncology. 53(4). 480–487. 2 indexed citations
3.
Brecelj, Erik, Mirko Omejc, Franc Anderluh, et al.. (2019). Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia. Radiology and Oncology. 53(4). 465–472. 9 indexed citations
4.
Velenik, Vaneja, Janja Ocvirk, Erik Brecelj, et al.. (2019). Total neoadjuvant treatment of “ugly” rectal cancers in Slovenia. Annals of Oncology. 30. iv34–iv34.
5.
But-Hadžić, Jasna, Franc Anderluh, Erik Brecelj, et al.. (2018). Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial. Radiology and Oncology. 52(3). 267–274. 17 indexed citations
6.
Velenik, Vaneja, Mirko Omejc, Janja Ocvirk, et al.. (2018). Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer. Annals of Oncology. 29. v89–v90.
7.
But-Hadžić, Jasna, Franc Anderluh, Erik Brecelj, et al.. (2016). Acute Toxicity and Tumor Response in Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy With Shortening of the Overall Treatment Time Using Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost: A Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 96(5). 1003–1010. 23 indexed citations
8.
9.
Perpar, Ana, Erik Brecelj, Nada Rotovnik Kozjek, et al.. (2014). Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment. Radiology and Oncology. 49(2). 181–184. 2 indexed citations
10.
Oblak, Irena, et al.. (2013). Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma. Radiology and Oncology. 48(2). 189–196. 5 indexed citations
11.
Oblak, Irena, et al.. (2013). Capecitabine in Postoperative Radiochemotherapy for Gastric Adenocarcinoma. Annals of Oncology. 24. iv42–iv42. 2 indexed citations
12.
Oblak, Irena, et al.. (2012). Long term outcome after combined modality treatment for anal cancer. Radiology and Oncology. 46(2). 145–52. 23 indexed citations
13.
Velenik, Vaneja, Janja Ocvirk, Irena Oblak, & Franc Anderluh. (2012). Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial. Radiology and Oncology. 46(3). 252–7. 16 indexed citations
14.
Oblak, Irena, et al.. (2011). Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III. Radiology and Oncology. 45(3). 209–12. 5 indexed citations
15.
Kozjek, Nada Rotovnik, Lidija Kompan, Peter B. Soeters, et al.. (2011). Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: A randomised double blinded, placebo controlled pilot study. Clinical Nutrition. 30(5). 567–570. 32 indexed citations
16.
Velenik, Vaneja, Janja Ocvirk, Maja Marolt Mušič, et al.. (2011). Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. Radiation Oncology. 6(1). 105–105. 64 indexed citations
17.
Velenik, Vaneja, Irena Oblak, & Franc Anderluh. (2010). Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiation Oncology. 5(1). 88–88. 23 indexed citations
18.
Oblak, Irena, et al.. (2009). Anal cancer chemoirradiation with curative intent – a single institution experience. Neoplasma. 56(2). 150–155. 6 indexed citations
19.
Velenik, Vaneja, Janja Ocvirk, Irena Oblak, & Franc Anderluh. (2009). A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer. European Journal of Surgical Oncology. 36(3). 244–250. 40 indexed citations
20.
Oblak, Irena, Vaneja Velenik, Franc Anderluh, & Primož Strojan. (2007). Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia. European Journal of Surgical Oncology. 33(8). 982–987. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucyna Pietrzak Breakdown of academic impact, for papers by Mara Gisabella Breakdown of academic impact, for papers by Giovanni Boz Breakdown of academic impact, for papers by R. Innocente Breakdown of academic impact, for papers by Christian Sturesson Breakdown of academic impact, for papers by Alice Dewdney Breakdown of academic impact, for papers by P Ségol Breakdown of academic impact, for papers by T Kobayashi Breakdown of academic impact, for papers by Shinsuke Masubuchi Breakdown of academic impact, for papers by Nadim Bashir
Rankless by CCL
2026